Trials / Sponsors / Targovax Oy
Targovax Oy
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Melanoma | Phase 2 | 2024-01-01 |
| Completed | A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab Advanced or Unresectable Melanoma Progressing After PD1 Blockade | Phase 1 | 2016-12-01 |
| Unknown | A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming G To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy | Phase 1 / Phase 2 | 2016-06-01 |
| Completed | ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers Malignant Solid Tumour | Phase 1 | 2012-04-01 |